“we don't know more than they do and it's dising
Post# of 148155
I know enough to know more data is better and a few extra patients (which are easy to enroll) could be very useful when analyzing the data. I also know that Cytodyn trial size and distribution hasn’t been optimal in the past - so please forgive me if I’m not completely trusting. But hey, then again we can just blame the FDA if it doesn’t work out.
Read More: https://investorshangout.com/post/newpost/605...z6rVmkkQYi